Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Robert Burns downgraded ADC Therapeutics SA (NYSE:ADCT) from Buy to Neutral.
ADC Therapeutics shares closed at $1.0250 on Friday.
See how other analysts view this stock.
Wall Street analysts changed ratings on top stocks. Check out the complete list on Benzinga's analyst ratings page. AMAT was…
Discover why ADC Therapeutics (NYSE:ADCT) stock is tumbling on Friday as a prominent Wall Street analyst slashes targets due to…
Analysts changed outlook on top names, including SMMT, DAVA. See what others think before buying SMMT stock.
Top Wall Street analysts changed outlook on top names; see all changes on analyst ratings page. Analysts have mixed views on ZS…
U.S. stock futures down on tech profit-taking and weak guidance, ADC Therapeutics shares plunge 50.67%, other stocks also slide.
Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. Analysts have mixed views on INGR…
